These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 26884552)

  • 1. Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer.
    Carroll JS
    Eur J Endocrinol; 2016 Jul; 175(1):R41-9. PubMed ID: 26884552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy.
    Shao W; Brown M
    Breast Cancer Res; 2004; 6(1):39-52. PubMed ID: 14680484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen receptor negativity in breast cancer: a cause or consequence?
    Gajulapalli VNR; Malisetty VL; Chitta SK; Manavathi B
    Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27884978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of the oestrogen receptor in breast cancer.
    Kok M; Linn SC
    Neth J Med; 2010 Oct; 68(10):291-302. PubMed ID: 21071774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.
    Yoshida T; Eguchi H; Nakachi K; Tanimoto K; Higashi Y; Suemasu K; Iino Y; Morishita Y; Hayashi S
    Carcinogenesis; 2000 Dec; 21(12):2193-201. PubMed ID: 11133808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrogating the genome to understand oestrogen-receptor-mediated transcription.
    Dietz SC; Carroll JS
    Expert Rev Mol Med; 2008 Apr; 10():e10. PubMed ID: 18377699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of estrogen and progesterone receptor gene expression in human breast cancer.
    Lapidus RG; Nass SJ; Davidson NE
    J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):85-94. PubMed ID: 10819507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance.
    Nardone A; Weir H; Delpuech O; Brown H; De Angelis C; Cataldo ML; Fu X; Shea MJ; Mitchell T; Veeraraghavan J; Nagi C; Pilling M; Rimawi MF; Trivedi M; Hilsenbeck SG; Chamness GC; Jeselsohn R; Osborne CK; Schiff R
    Br J Cancer; 2019 Feb; 120(3):331-339. PubMed ID: 30555156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
    Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
    Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
    Alles MC; Gardiner-Garden M; Nott DJ; Wang Y; Foekens JA; Sutherland RL; Musgrove EA; Ormandy CJ
    PLoS One; 2009; 4(3):e4710. PubMed ID: 19270750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors.
    Nembrot M; Quintana B; Mordoh J
    Biochem Biophys Res Commun; 1990 Jan; 166(2):601-7. PubMed ID: 2302226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome- and proteome-oriented identification of dysregulated eIF4G, STAT3, and Hippo pathways altered by PIK3CA
    Cheng F; Zhao J; Hanker AB; Brewer MR; Arteaga CL; Zhao Z
    Breast Cancer Res Treat; 2016 Dec; 160(3):457-474. PubMed ID: 27771839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.
    Giannoudis A; Malki MI; Rudraraju B; Mohhamed H; Menon S; Liloglou T; Ali S; Carroll JS; Palmieri C
    Breast Cancer Res; 2020 Nov; 22(1):126. PubMed ID: 33198803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.
    Abdel-Fatah TM; Perry C; Moseley P; Johnson K; Arora A; Chan S; Ellis IO; Madhusudan S
    Breast Cancer Res Treat; 2014 Feb; 143(3):411-21. PubMed ID: 24381055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.
    Frasor J; El-Shennawy L; Stender JD; Kastrati I
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 3(0 3):235-9. PubMed ID: 25450861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of estrogen receptor alpha function in breast cancer.
    Ferguson AT; Davidson NE
    Crit Rev Oncog; 1997; 8(1):29-46. PubMed ID: 9516085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomics-based identification of oestrogen-regulated long noncoding RNAs in ER+ breast cancer.
    Zhang Z; Yu W; Tang D; Zhou Y; Bi M; Wang H; Zheng Y; Chen M; Li L; Xu X; Zhang W; Tao H; Jin VX; Liu Z; Chen L
    RNA Biol; 2020 Nov; 17(11):1590-1602. PubMed ID: 32506995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of ER(estrogen receptor) gene expression in the genesis and development of breast cancer].
    Hayashi S; Yoshida T
    Nihon Rinsho; 2000 Feb; 58(2):495-503. PubMed ID: 10707581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers.
    Brimmell M; Burns JS; Munson P; McDonald L; O'Hare MJ; Lakhani SR; Packham G
    Br J Cancer; 1999 Nov; 81(6):1042-51. PubMed ID: 10576663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse regulation of oestrogen receptor and epidermal growth factor receptor gene expression in MCF-7 breast cancer cells treated with phorbol ester.
    Lee CS; deFazio A; Ormandy CJ; Sutherland RL
    J Steroid Biochem Mol Biol; 1996 Jun; 58(3):267-75. PubMed ID: 8836162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.